2022
DOI: 10.1371/journal.pone.0267725
|View full text |Cite
|
Sign up to set email alerts
|

Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort–EPICOV

Abstract: Background We aimed to study whether social patterns of exposure to SARS-CoV-2 infection changed in France throughout the year 2020, in light to the easing of social contact restrictions. Methods A population-based cohort of individuals aged 15 years or over was randomly selected from the national tax register to collect socio-economic data, migration history, and living conditions in May and November 2020. Home self-sampling on dried blood was proposed to a 10% random subsample in May and to all in November… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
12
1
2

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 33 publications
2
12
1
2
Order By: Relevance
“…Currently, there are limited data regarding the reliability of remote sample collection for SARS-CoV-2 antibody testing. Many seroprevalence studies for COVID-19 have used dried blood spot cards collected remotely [ 20 , 21 , 22 , 23 , 24 , 25 , 26 ], but they can have a non-uniform blood distribution and uncertain collection volume [ 21 , 27 ]. One way to mitigate this issue of non-uniform blood distribution is the use of a volumetric sampling device, such as the Tasso-SST (Tasso, Inc, Seattle, Washington) device for capillary blood self-collection.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there are limited data regarding the reliability of remote sample collection for SARS-CoV-2 antibody testing. Many seroprevalence studies for COVID-19 have used dried blood spot cards collected remotely [ 20 , 21 , 22 , 23 , 24 , 25 , 26 ], but they can have a non-uniform blood distribution and uncertain collection volume [ 21 , 27 ]. One way to mitigate this issue of non-uniform blood distribution is the use of a volumetric sampling device, such as the Tasso-SST (Tasso, Inc, Seattle, Washington) device for capillary blood self-collection.…”
Section: Introductionmentioning
confidence: 99%
“…Family income and population density in the municipality of residence were associated with the probability of extra-but not intra-household infection, which allows a better understanding of the association of these factors with the seroprevalence previously described in the EpiCov cohort 11,12 . Surprisingly, we did not find an association between within-household person-to-person transmission and overcrowded housing or accommodation type, by opposition to some previous studies which reported associations between housing surface areas and secondary infection rates in households 27,28 .…”
Section: Discussionmentioning
confidence: 87%
“…This period covers the first two waves of the COVID-19 pandemic, mostly caused by the wildtype virus before the alpha variant gradually became dominant after its introduction at the end of 2020 18 and before the start of the vaccination campaign on December 27, 2020 19 . The epidemiological evolution during the year 2020 in France has been described elsewhere 12 and is briefly detailed in Supplementary Note 1.…”
Section: Methodsmentioning
confidence: 99%
“…Por el contrario, la seroprevalencia en los migrantes con vocación de permanencia estudiados fue mayor a la reportada en tres estudios 19,20,21 . El primero realizado en la provincia de Hai Duong, Vietnam, entre enero y febrero de 2021, que incluyó un subgrupo de trabajadores migrantes, sintomáticos y asintomáticos, que se encontraban en dos instalaciones de cuarentena por tener contacto con convivientes con COVID-19, y que reportó una seroprevalencia de 0,47% (1/212) 19 .…”
Section: Discussionunclassified
“…El segundo estudio realizado en Francia, que incluyó población migrante de primera generación nacidos en Europa y fuera de Europa, encontró una seroprevalencia en mayo de 2020 de 3,8% y 9,2%, respectivamente en estas subpoblaciones. Además, para noviembre de 2020, la seroprevalencia aumentó a 5,2% en los migrantes nacidos en Europa y a 13,3% en los nacidos fuera de Europa 20 . Y el tercer estudio, realizado en Omán entre julio y noviembre de 2020 en población asintomática mayor de 4 años, que reportó una seroprevalencia en migrantes de 9,1% en la evaluación basal, la cual aumentó a 16,8% entre 8 y 16 semanas más tarde 21 .…”
Section: Discussionunclassified